Kaiser Permanente gives $1M and provides 1st-ever injection of investigational vaccine

Kaiser Permanente has been very active in providing support among communities across the country during the novel coronavirus pandemic. The organization will donate $1 million to public health organizations and has given the first-ever injection of an investigational vaccine for the 2019 novel coronavirus.

Kaiser Permanente is contributing $1 million to 10 leading public health organizations and collaborating with CDC Foundation to strengthen the United States’ public health infrastructure and response systems to stop the spread of COVID-19, the disease caused by the novel coronavirus.

In addition to their contribution, Kaiser Permanente Washington Health Research Institute gave the first-ever injection of an investigational vaccine for the 2019 novel coronavirus, SARS-CoV-2, to volunteers participating in phase one of the federally sponsored clinical trial.

For more information, visit Kaiser Permanente’s website.

Source: Kaiser Permanente

Also see: Coverage of GBC Member Companies’ philanthropic responses to COVID-19

Comments are closed.